[Fingerprint of Shenmai Injection based on ~1H-NMR technique].

Zhongguo Zhong Yao Za Zhi

Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University Hangzhou 310058, China Innovation Center in Zhejiang University, State Key Laboratory of Component-Based Chinese Medicine Hangzhou 310058, China.

Published: February 2022

Shenmai Injection is a Chinese medicinal injection prepared from Ginseng Radix et Rhizoma Rubra and Ophiopogonis Radix, which is widely used in clinical practice for the treatment and adjuvant therapy of cardiovascular diseases with significant pharmacological effects. Proton nuclear magnetic resonance spectroscopy(~1H-NMR) has the advantages of simple and nondestructive sample pretreatment, fast analysis, abundant chemical information, quantification and no need to follow the standard curve. It is widely used in the analysis and research of complex mixtures of traditional Chinese medicine, clinical blood and urine samples. In this study, the ~1H-NMR fingerprint of Shenmai Injection was established. Thirty-two chemical components were identified, including seven amino acids, eight small molecular organic acids, one alkaloid, four sugars, two nucleosides, seven saponins, and three other components. Pearson's correlation coefficient and multivariate analysis of variance(principal component analysis combined with hierarchical cluster analysis) were applied based on the ~1H-NMR fingerprint to evaluate the quality consistency. The results showed high-quality consistency of 82 batches of Shenmai Injection. This study confirms that the ~1H-NMR fingerprint has great potential in the application of quality control of Chinese medicinal injection.

Download full-text PDF

Source
http://dx.doi.org/10.19540/j.cnki.cjcmm.20211108.303DOI Listing

Publication Analysis

Top Keywords

shenmai injection
16
~1h-nmr fingerprint
12
based ~1h-nmr
8
chinese medicinal
8
medicinal injection
8
injection
6
analysis
5
[fingerprint shenmai
4
injection based
4
~1h-nmr
4

Similar Publications

Chinese patent medicines play a crucial role in the treatment of chronic pulmonary heart disease(CPHD). Nowadays, there is still a lack of comprehensive control over clinical research evidence in this field. This study aims to summarize the clinical research on the treatment of CPHD with Chinese patent medicines using an evidence map, in order to understand the current status and deficiencies of evidence in this area.

View Article and Find Full Text PDF

Bayesian network Meta-analysis was conducted to assess the efficacy and safety of different Chinese medicine injections for dilated cardiomyopathy(DCM). CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, EMbase, Cochrane Library, ProQuest, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov were searched for the randomized controlled trial(RCT) from the inception to January 2024.

View Article and Find Full Text PDF

Comparative efficacy of Chinese tonic medicines for treating sepsis or septic shock: A systematic review and Bayesian network meta-analysis of randomized controlled trials.

Phytomedicine

November 2024

West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address:

Background: Sepsis or septic shock is a life-threatening medical emergency with a poor prognosis and a high economic burden for both individuals and healthcare resources. Evidence suggests that Chinese tonic medicines (CTMs), as adjuvant treatments, are effective in treating this disease. Nevertheless, the ongoing discourse regarding the optimal CTMs persists.

View Article and Find Full Text PDF

Study on the mechanism of Shenmai injection in the treatment of sepsis.

J Cell Mol Med

November 2024

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.

Article Synopsis
  • Shenmai injection (SMI) is commonly used to treat sepsis, and this study investigates its unclear molecular mechanism using advanced tech like network pharmacology and molecular docking.* -
  • Researchers identified 122 potential therapeutic targets and 28 key targets, with findings highlighting the PI3K-AKT, RAP1, and MAPK signaling pathways as significantly enriched.* -
  • The study reveals that SMI may work through multiple targets related to anti-inflammatory, anti-oxidative, and immune regulation processes, offering insights for future sepsis research.*
View Article and Find Full Text PDF

Purpose: To evaluate the efficacy and safety of Shenmai injection for the treatment of viral myocarditis (VMS) through systematic evaluation and meta-analysis.

Methods: Seven databases were searched to identify randomized controlled trials that examined the use of Shenmai injection for the treatment of VMS. The databases were searched from inception to 20 January 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!